Rare Renal Disorders
Congress materials
View posters, abstracts and other materials about rare renal disorders presented at recent congresses.
The information on this page pertains to select congresses and congress materials. It is not intended to serve as a comprehensive overview of all congresses and congress materials. Please note that congress materials may include information about uses for which a product is not approved and/or information that is inconsistent with the product uses described in FDA-required labeling. Novo Nordisk does not suggest or recommend the use of its products in any manner other than as described in their FDA-required labeling. Please also note that all tables or figures derived from publications and presentations are copyright-protected works. You may not reproduce, prepare derivative works from, display or distribute these works unless you obtain the permission of the copyright owner, or as otherwise may be permitted by law.
We didn't find any resources that match your selection.
Please adjust your filter(s) and try again.
American Society of Nephrology (ASN) Annual Meeting
View posters and presentations from the ASN Kidney Week conference on the Novo Nordisk Science Hub.
Find more information
Find product information
Explore our portfolio of products for treating rare renal disorders, including prescribing information, safety data sheets and storage and stability information.
Continuing education
Explore accredited education opportunities for rare renal disorders, supported by Novo Nordisk and provided by third-party organizations.
The purpose of this site is to provide relevant medical and scientific information about Novo Nordisk products and areas of therapeutic interest. Information about investigational products or investigational uses of approved products neither implies FDA approval for these products or uses, nor establishes the safety or efficacy of these products or uses. There is no guarantee that any investigational product or investigational use will receive FDA approval or become commercially available in the United States. Novo Nordisk does not recommend or suggest use of its products in any manner inconsistent with FDA-approved labeling.
This site is intended for United States healthcare professionals only. The information on this site—including all product information—pertains to residents of the United States only. Any products referenced on this site may have different labelling in different countries.
